收费全文 | 183411篇 |
免费 | 17837篇 |
国内免费 | 11418篇 |
耳鼻咽喉 | 1524篇 |
儿科学 | 2271篇 |
妇产科学 | 2133篇 |
基础医学 | 25367篇 |
口腔科学 | 3196篇 |
临床医学 | 22328篇 |
内科学 | 25308篇 |
皮肤病学 | 1993篇 |
神经病学 | 8598篇 |
特种医学 | 6437篇 |
外国民族医学 | 80篇 |
外科学 | 17626篇 |
综合类 | 31590篇 |
现状与发展 | 46篇 |
一般理论 | 17篇 |
预防医学 | 13747篇 |
眼科学 | 4363篇 |
药学 | 20988篇 |
166篇 | |
中国医学 | 10447篇 |
肿瘤学 | 14441篇 |
2024年 | 712篇 |
2023年 | 2739篇 |
2022年 | 7132篇 |
2021年 | 9080篇 |
2020年 | 6708篇 |
2019年 | 5899篇 |
2018年 | 6216篇 |
2017年 | 5873篇 |
2016年 | 5493篇 |
2015年 | 8036篇 |
2014年 | 9992篇 |
2013年 | 9850篇 |
2012年 | 13714篇 |
2011年 | 14517篇 |
2010年 | 10304篇 |
2009年 | 8417篇 |
2008年 | 9979篇 |
2007年 | 10041篇 |
2006年 | 9165篇 |
2005年 | 8321篇 |
2004年 | 6664篇 |
2003年 | 6750篇 |
2002年 | 5749篇 |
2001年 | 4715篇 |
2000年 | 3871篇 |
1999年 | 3357篇 |
1998年 | 2084篇 |
1997年 | 2204篇 |
1996年 | 1507篇 |
1995年 | 1455篇 |
1994年 | 1320篇 |
1993年 | 906篇 |
1992年 | 1124篇 |
1991年 | 1032篇 |
1990年 | 904篇 |
1989年 | 823篇 |
1988年 | 721篇 |
1987年 | 620篇 |
1986年 | 584篇 |
1985年 | 472篇 |
1984年 | 391篇 |
1983年 | 327篇 |
1982年 | 279篇 |
1981年 | 241篇 |
1980年 | 201篇 |
1979年 | 210篇 |
1978年 | 198篇 |
1977年 | 221篇 |
1976年 | 198篇 |
1974年 | 163篇 |
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献Methods: This is a retrospective analysis of discharge records from the National Inpatient Sample database for patients receiving allo-HSCT between 1 January 2009 and 31 December 2013. Allo-HSCT discharges with an aGVHD diagnosis were included in the aGVHD group and those without any graft-versus-host disease (GVHD) diagnosis comprised the non-GVHD group. Mortality, LOS and costs were compared between the two groups, as well as within subgroups, including age (<18 vs. ≥18 years) and survival status (alive vs. deceased) at discharge.
Results: Overall, mortality (16.2% vs. 5.3%; p?<?.01), median hospital LOS (42.0 vs. 26.0 days; p?<?.01) and median total costs ($173,144 vs. $98,982; p?<?.01) were significantly increased in patients with aGVHD versus those without GVHD during hospitalizations for allo-HSCT, irrespective of age group. Patients with aGVHD who were <18 years of age had a lower mortality rate but greater hospital LOS and total costs versus patients aged ≥18 years. Patients who died during allo-HSCT hospitalization had longer LOS and incurred greater costs than those who survived in both the aGVHD and non-GVHD groups.
Conclusion: Occurrence of aGVHD during allo-HSCT admissions resulted in a tripling of the mortality rate and a near doubling of hospital LOS and total costs. In addition, death during allo-HSCT hospitalizations was associated with greater healthcare utilization and costs. Effectively mitigating aGVHD may improve survival and substantially reduce hospital LOS and costs for allo-HSCT. 相似文献